About
Taudia develops ultrasensitive protein biomarker quantification technology for neurodegenerative diseases, enabling biomarker detection using standard qPCR instruments.
Explore Taudia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.